Close

Form 13F-HR SUVRETTA CAPITAL MANAGEM For: Mar 31

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/20/2024

1. NFLX
2. TSM
3. ISRG
4. TSLA
5. SPY
6. INFY
7. SNV
8. SMCI
9. SLB
10. PPG


May 16, 2022 10:18 AM EDT

The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F COVER PAGE
OMB APPROVAL
OMB Number: 3235-0006
Expires: July 31, 2015
Estimated average burden
hours per response: 23.8
Report for the Calendar Year or Quarter Ended: 03-31-2022
Check here if Amendment   Amendment Number:
This Amendment (Check only one.):   is a restatement.
  adds new holdings entries.
Institutional Investment Manager Filing this Report:
Name: SUVRETTA CAPITAL MANAGEMENT, LLC
Address: 540 Madison Avenue
7th Floor
New York , NY10022
Form 13F File Number: 028-15929

The institutional investment manager filing this report and the person by whom it is signed hereby represent that the person signing the report is authorized to submit it, that all information contained herein is true, correct and complete, and that it is understood that all required items, statements, schedules, lists, and tables, are considered integral parts of this form.

Person Signing this Report on Behalf of Reporting Manager:
Name: Glenn Shepard
Title: Chief Financial Officer
Phone: 212-702-5204
Signature, Place, and Date of Signing:
/s/ Glenn Shepard New York , NY 05-16-2022
[Signature] [City, State] [Date]
Report Type (Check only one.):
X 13F HOLDINGS REPORT. (Check here if all holdings of this reporting manager are reported in this report.)
  13F NOTICE. (Check here if no holdings reported are in this report, and all holdings are reported by other reporting manager(s).)
  13F COMBINATION REPORT. (Check here if a portion of the holdings for this reporting manager are reported in this report and a portion are reported by other reporting manager(s).)
Form 13F Summary Page
Report Summary:
Number of Other Included Managers: 0
Form 13F Information Table Entry Total: 87
Form 13F Information Table Value Total: 3,273,687
(thousands)
List of Other Managers Reporting for this Manager:
[If there are no entries in this list, omit this section.]
Form 13F File Number Name

List of Other Included Managers:
Provide a numbered list of the name(s) and Form 13F file number(s) of all institutional investment managers with respect to which this report is filed, other than the manager filing this report.
[If there are no entries in this list, state “NONE” and omit the column headings and list entries.]
No. Form 13F File Number Name

The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Expires: July 31, 2015
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
AEGLEA BIOTHERAPEUTICS INC COM 00773J103 9,338 4,059,894 SH SOLE 4,059,894 0 0
AGIOS PHARMACEUTICALS INC COM 00847X104 34,273 1,177,374 SH SOLE 1,177,374 0 0
AMAZON COM INC COM 023135106 147,095 45,122 SH SOLE 45,122 0 0
AMBRX BIOPHARMA INC SPONSORED ADS 02290A102 6,146 1,491,832 SH SOLE 1,491,832 0 0
AMERISOURCEBERGEN CORP COM 03073E105 59,275 383,138 SH SOLE 383,138 0 0
ARCELLX INC COMMON STOCK 03940C100 21,493 1,533,059 SH SOLE 1,533,059 0 0
AURINIA PHARMACEUTICALS INC COM 05156V102 4,268 344,755 SH SOLE 344,755 0 0
BATH & BODY WORKS INC COM 070830104 49,647 1,038,630 SH SOLE 1,038,630 0 0
BCLS ACQUISITION CORP COM CL A G0904B105 1,974 200,000 SH SOLE 200,000 0 0
BENITEC BIOPHARMA INC COM 08205P100 1,796 769,000 SH SOLE 769,000 0 0
BIOHAVEN PHARMACTL HLDG CO L COM G11196105 7,308 61,631 SH SOLE 61,631 0 0
BOLT BIOTHERAPEUTICS INC COM 097702104 6,111 2,230,250 SH SOLE 2,230,250 0 0
CANO HEALTH INC *W EXP 06/03/202 13781Y111 1,065 674,066 SH SOLE 674,066 0 0
CANO HEALTH INC COM CL A 13781Y103 23,295 3,668,478 SH SOLE 3,668,478 0 0
CENTENE CORP DEL COM 15135B101 100,793 1,197,206 SH SOLE 1,197,206 0 0
CHIMERIX INC COM 16934W106 12,671 2,766,619 SH SOLE 2,766,619 0 0
CHINOOK THERAPEUTICS INC COM 16961L106 23,464 1,434,200 SH SOLE 1,434,200 0 0
DANAHER CORPORATION COM 235851102 68,220 232,570 SH SOLE 232,570 0 0
DECIBEL THERAPEUTICS INC COM 24343R106 801 263,600 SH SOLE 263,600 0 0
DECKERS OUTDOOR CORP COM 243537107 39,006 142,477 SH SOLE 142,477 0 0
ENTRADA THERAPEUTICS INC COM 29384C108 995 106,000 SH SOLE 106,000 0 0
EUCRATES BIOMEDICAL ACQU COR SHS G3141W106 984 99,999 SH SOLE 99,999 0 0
EUCRATES BIOMEDICAL ACQU COR *W EXP 10/23/202 G3141W122 6 33,333 SH SOLE 33,333 0 0
EUROPEAN BIOTECH ACQUTN CORP *W EXP 03/06/202 G3167F128 20 100,000 SH SOLE 100,000 0 0
EUROPEAN BIOTECH ACQUTN CORP CLASS A ORD SHS G3167F102 2,922 300,000 SH SOLE 300,000 0 0
EYEPOINT PHARMACEUTICALS INC COM NEW 30233G209 35,349 2,909,407 SH SOLE 2,909,407 0 0
FRAZIER LIFESCIENCES ACQU CO CL A SHS G3710A105 860 87,498 SH SOLE 87,498 0 0
FRAZIER LIFESCIENCES ACQU CO *W EXP 11/30/202 G3710A113 7 29,166 SH SOLE 29,166 0 0
FULCRUM THERAPEUTICS INC COM 359616109 61,807 2,613,412 SH SOLE 2,613,412 0 0
GEMINI THERAPEUTICS INC COM 36870G105 3,297 2,372,267 SH SOLE 2,372,267 0 0
GFL ENVIRONMENTAL INC SUB VTG SHS 36168Q104 74,337 2,284,496 SH SOLE 2,284,496 0 0
HERON THERAPEUTICS INC COM 427746102 16,411 2,869,048 SH SOLE 2,869,048 0 0
HILTON WORLDWIDE HLDGS INC COM 43300A203 55,037 362,703 SH SOLE 362,703 0 0
HUMANA INC COM 444859102 82,198 188,888 SH SOLE 188,888 0 0
IMMUNEERING CORP CLASS A COM 45254E107 1,294 200,000 SH SOLE 200,000 0 0
INFLARX NV COM N44821101 6,012 3,285,000 SH SOLE 3,285,000 0 0
INOZYME PHARMA INC COM 45790W108 4,144 1,013,216 SH SOLE 1,013,216 0 0
INSMED INC COM PAR $.01 457669307 30,983 1,318,432 SH SOLE 1,318,432 0 0
INTRA-CELLULAR THERAPIES INC COM 46116X101 93,738 1,531,923 SH SOLE 1,531,923 0 0
IOVANCE BIOTHERAPEUTICS INC COM 462260100 6,763 406,200 SH SOLE 406,200 0 0
IQVIA HLDGS INC COM 46266C105 89,411 386,710 SH SOLE 386,710 0 0
JOHNSON & JOHNSON COM 478160104 73,605 415,310 SH SOLE 415,310 0 0
KALVISTA PHARMACEUTICALS INC COM 483497103 25,740 1,746,300 SH SOLE 1,746,300 0 0
KEZAR LIFE SCIENCES INC COM 49372L100 23,433 1,409,956 SH SOLE 1,409,956 0 0
KURA ONCOLOGY INC COM 50127T109 62,600 3,893,019 SH SOLE 3,893,019 0 0
LAS VEGAS SANDS CORP COM 517834107 88,440 2,275,282 SH SOLE 2,275,282 0 0
LAUDER ESTEE COS INC CL A 518439104 101,432 372,475 SH SOLE 372,475 0 0
MARINUS PHARMACEUTICALS INC COM NEW 56854Q200 25,862 2,766,000 SH SOLE 2,766,000 0 0
MARQETA INC CLASS A COM 57142B104 44,711 4,049,950 SH SOLE 4,049,950 0 0
MARRIOTT INTL INC NEW CL A 571903202 54,349 309,240 SH SOLE 309,240 0 0
MASTERCARD INCORPORATED CL A 57636Q104 68,239 190,943 SH SOLE 190,943 0 0
MCKESSON CORP COM 58155Q103 29,995 97,980 SH SOLE 97,980 0 0
MEIRAGTX HLDGS PLC COM G59665102 479 34,600 SH SOLE 34,600 0 0
MEREO BIOPHARMA GROUP PLC ADS 589492107 10,239 9,142,067 SH SOLE 9,142,067 0 0
MICROSOFT CORP COM 594918104 183,675 595,747 SH SOLE 595,747 0 0
MIRATI THERAPEUTICS INC COM 60468T105 41,959 510,331 SH SOLE 510,331 0 0
MOLECULAR PARTNERS AG ADS 60853G106 8,220 400,000 SH SOLE 400,000 0 0
NATERA INC COM 632307104 23,784 584,660 SH SOLE 584,660 0 0
OMEGA ALPHA SPAC CL A G6749V107 2,946 300,000 SH SOLE 300,000 0 0
OPY ACQUISITION CORP I UNIT 09/22/2026 671005205 1,999 200,000 SH SOLE 200,000 0 0
ORIC PHARMACEUTICALS INC COM 68622P109 2,353 440,696 SH SOLE 440,696 0 0
OTIS WORLDWIDE CORP COM 68902V107 99,841 1,297,480 SH SOLE 1,297,480 0 0
OTONOMY INC COM 68906L105 7,546 3,144,196 SH SOLE 3,144,196 0 0
PHARVARIS N V COM N69605108 15,007 827,540 SH SOLE 827,540 0 0
POINT BIOPHARMA GLOBAL INC COM 730541109 24,025 3,014,408 SH SOLE 3,014,408 0 0
RESEARCH ALLIANCE CORP II COM CL A 760873109 4,885 500,000 SH SOLE 500,000 0 0
RH COM 74967X103 59,295 181,835 SH SOLE 181,835 0 0
ROIVANT SCIENCES LTD SHS G76279101 3,367 681,528 SH SOLE 681,528 0 0
ROYALTY PHARMA PLC SHS CLASS A G7709Q104 78,918 2,025,610 SH SOLE 2,025,610 0 0
S&P GLOBAL INC COM 78409V104 84,809 206,760 SH SOLE 206,760 0 0
SCHWAB CHARLES CORP COM 808513105 82,859 982,790 SH SOLE 982,790 0 0
SELECT SECTOR SPDR TR ENERGY 81369Y506 52,963 692,868 SH SOLE 692,868 0 0
SIO GENE THERAPIES INC COMMON 829399104 3,962 5,914,000 SH SOLE 5,914,000 0 0
SOLID BIOSCIENCES INC COM 83422E105 8,670 7,224,860 SH SOLE 7,224,860 0 0
SPDR SER TR S&P OILGAS EXP 78468R556 22,197 164,970 SH SOLE 164,970 0 0
SUTRO BIOPHARMA INC COM 869367102 30,680 3,732,400 SH SOLE 3,732,400 0 0
TAPESTRY INC COM 876030107 86,192 2,320,100 SH SOLE 2,320,100 0 0
TERNS PHARMACEUTICALS INC COM 880881107 3,679 1,238,800 SH SOLE 1,238,800 0 0
THERMO FISHER SCIENTIFIC INC COM 883556102 67,966 115,069 SH SOLE 115,069 0 0
TURMERIC ACQUISITION CORP CL A G9127T108 1,970 200,000 SH SOLE 200,000 0 0
TURMERIC ACQUISITION CORP *W EXP 10/08/202 G9127T124 22 66,666 SH SOLE 66,666 0 0
ULTRAGENYX PHARMACEUTICAL IN COM 90400D108 38,133 525,100 SH SOLE 525,100 0 0
UNION PAC CORP COM 907818108 167,649 613,628 SH SOLE 613,628 0 0
UNITEDHEALTH GROUP INC COM 91324P102 122,901 240,997 SH SOLE 240,997 0 0
VISA INC COM CL A 92826C839 97,133 437,990 SH SOLE 437,990 0 0
WYNN RESORTS LTD COM 983134107 29,190 366,060 SH SOLE 366,060 0 0
XENON PHARMACEUTICALS INC COM 98420N105 21,154 692,000 SH SOLE 692,000 0 0

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

SEC Filings